Fig. 8From: ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancerInfluence of ANLN on cell cycle associated proteins. Western blot analysis showed efficient knockdown of ANLN expression by two different siRNAs. Overall, ANLN siRNA knockdown resulted in lower expression of cyclin D1, cyclin A2 and cyclin B1compared to controls in SKBR3 and T47D breast cancer cell lines. B-actin was used as a loading controlBack to article page